SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Cadila Healthcare to exit from its business in Japan

27 Jan 2014 Evaluate

Cadila Healthcare has decided to exit from its business in Japan, which is through 100% subsidiary Company after completing portfolio and strategy review of its business.

Cadila Healthcare, the flagship company of Zydus Cadila Group, focuses on various areas, such as formulations (human and veterinary), new drug discovery, novel drug delivery, pharmaceutical ingredients, analytical research, phytochemistry, biotechnology, plant tissue culture, etc.

Zydus Lifesciences Share Price

943.10 4.20 (0.45%)
11-May-2026 12:15 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1873.30
Dr. Reddys Lab 1293.35
Cipla 1317.60
Zydus Lifesciences 943.10
Lupin 2252.80
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×